Jan 17, 2017 at 21:16 | Source: Moneycontrol.com
Glenmark Pharmaceuticals' board meeting will be held on February 02, 2017, to consider and approve the Company's Unaudited Financial Statements for the Third Quarter and Nine months ended December 31, 2016 (Q3). Further, as per the
Jan 17, 2017 at 16:02 | Source: Moneycontrol.com
Net Sales are expected to increase by 0.9 percent Q-o-Q (down 27.1 percent Y-o-Y) to Rs 2190 crore, according to HDFC Securities.
Jan 16, 2017 at 12:17 | Source: Moneycontrol.com
Net Sales are expected to increase by 11.6 percent Q-o-Q (up 39.6 percent Y-o-Y) to Rs 2482.5 crore, according to ICICI Securities.
Jan 14, 2017 at 14:00 | Source: Moneycontrol.com
Analysts predict Q3 to be a tough quarter with revenue growth moderating to 11.7 percent in October-December period compared to 18.4 percent compounded annual growth rate (CAGR) over last 10 years
Jan 12, 2017 at 12:29 | Source: CNBC-TV18
Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today -- Idea Cellular, Sun Pharma, DRL, Lupin, Aurobindo Pharma , Glenmark, Natco Pharma, Alkem Labs, Ajanta Pharma, Strides Shasun, Biocon, Cipla, Cyient, MMTC and Power Grid.
Jan 06, 2017 at 09:53 | Source: CNBC-TV18
Speaking to CNBC-TV18 Sandeep Bhatia, Head of Equity, India at Macquarie said that markets could trend down over the next couple of months. Any 10 percent correction from current levels will be reasonable, he maintained.
Jan 06, 2017 at 08:01 | Source: CNBC-TV18
Wockhardt | Tech Mahindra | Sagar Cement | Glenmark | Torrent Pharma | Mastek | Piramal Enterprises | GE Power | Indo Borax | Monnet Ispat | Reliance Communications | GM Breweries and Chartered Logistics are stocks, which are in the news today.
Jan 03, 2017 at 15:04 | Source: CNBC-TV18
Rajat Bose of rajatkbose.com recommends buying IL&FS Transport and Glenmark Pharma.
Jan 03, 2017 at 09:29 | Source: CNBC-TV18
Mitesh Thacker of miteshthacker.com suggests buying Cummins India and NBCC and advises selling Glenmark Pharma.
Dec 30, 2016 at 08:22 | Source: Moneycontrol.com
Nomura is neutral on Lupin and Torrent. It has a buy rating on Dr Reddys and Cadila. It says trailing three-month sales declined sequentially for Torrent, Sun Pharma and Glenmark. Torrents sales were down on account of price erosion in gAbilify. Suns T3M sales declined QoQ due to price erosion and market share loss in gGleevec.